BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sahni S, Pandya AR, Hadden WJ, Nahm CB, Maloney S, Cook V, Toft JA, Wilkinson-White L, Gill AJ, Samra JS, Dona A, Mittal A. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma. Int J Cancer 2021;148:1508-18. [PMID: 33128797 DOI: 10.1002/ijc.33368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Cao Y, Zhao R, Guo K, Ren S, Zhang Y, Lu Z, Tian L, Li T, Chen X, Wang Z. Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma. Front Oncol 2022;11:744667. [DOI: 10.3389/fonc.2021.744667] [Reference Citation Analysis]
2 Hipperson L, Hadden WJ, Nahm CB, Gill AJ, Samra JS, Dona A, Mittal A, Sahni S. Urinary metabolite prognostic biomarker panel for pancreatic ductal adenocarcinomas. Biochim Biophys Acta Gen Subj 2021;1865:129966. [PMID: 34329704 DOI: 10.1016/j.bbagen.2021.129966] [Reference Citation Analysis]